PROTEOME SCIENCES PLC Logo

PROTEOME SCIENCES PLC

A Contract Research Organization focused on applied proteomics and peptidomics services.

PRM | IL

Overview

Corporate Details

ISIN(s):
GB0003104196
LEI:
213800Q62ICXANKU2986
Country:
United Kingdom
Address:
COVEHAM HOUSE, KT11 3EP COBHAM

Description

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-06 08:20
Two Further Substantial Contracts for PRM
English HTML 11.8 KB
2025-12-08 08:20
Substantial contract for Proteome Sciences
English HTML 12.4 KB
2025-11-25 08:25
Appointment of Nominated Adviser and Broker
English HTML 13.2 KB
2025-09-25 08:00
Interim Results
English HTML 188.1 KB
2025-05-16 14:17
Result of AGM
English HTML 10.7 KB
2025-05-16 13:00
AGM Statement
English HTML 12.4 KB
2025-04-10 08:00
Final Results
English HTML 236.2 KB
2025-04-04 14:00
Notice of Results and Investor Presentation
English HTML 12.6 KB
2025-02-21 08:00
Contract Win
English HTML 12.5 KB
2024-12-23 08:08
Loan Facility, Trading Update & Directorate Change
English HTML 17.8 KB
2024-09-13 08:00
Interim Results and Directorate Change
English HTML 183.4 KB
2024-05-16 14:10
Result of AGM
English HTML 10.5 KB
2024-05-16 08:00
AGM Statement
English HTML 11.9 KB
2024-04-26 08:00
Contract Win
English HTML 12.3 KB
2024-04-10 08:00
Final Results
English HTML 231.2 KB

Automate Your Workflow. Get a real-time feed of all PROTEOME SCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROTEOME SCIENCES PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROTEOME SCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.